Open Access
Med Sci (Paris)
Volume 34, Number 11, Novembre 2018
Page(s) 907 - 909
Section Le Magazine
Published online 10 December 2018
  1. Rous P.. Transmission of a malignant new growth by means of a cell-free filtrate. J Am Med Ass 1911 ; 56 : 198. [Google Scholar]
  2. Martin GS. Rous sarcoma virus: a function required for the maintenance of the transformed state. Nature 1970 ; 227 : 1021–1023. [CrossRef] [PubMed] [Google Scholar]
  3. Ivanov X, Mladenov Z, Nedyalkov S, et al. Experimental investigations into avian leucoses. V. transmission, haematology and morphology of avian myelocytomatosis. Bull Inst Pathol Comp Anim 1964; 10 : 5–38. [Google Scholar]
  4. Burkitt D.. A sarcoma involving the jaws in African children. Br J Sur 1958 ; 46 : 218–223. [CrossRef] [PubMed] [Google Scholar]
  5. Pommier Y, Kohn KW. Cycle cellulaire et points de contrôle en oncologie : nouvelles cibles thérapeutiques. Med Sci (Paris) 2003 ; 19 : 173–186. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Kovesdi I, Reichel R, Nevins JR. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 1986 ; 45 : 219–228. [CrossRef] [PubMed] [Google Scholar]
  7. Iritani BM, Eisenman RN. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci U S A 1999 ; 96 : 13180–13185. [CrossRef] [PubMed] [Google Scholar]
  8. Wu H, Kapoor P, Frappier L. Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J Virol 2002 ; 76 : 2480–2490. [PubMed] [Google Scholar]
  9. Yin Y, Manoury B, Fåhraeus R. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 2003 ; 301 : 1371–1374. [Google Scholar]
  10. Apcher S, Daskalogianni C, Manoury B, et al. Epstein Barr virusencoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation. PLoS Pathog 2010 ; 6 : e1001151. [CrossRef] [PubMed] [Google Scholar]
  11. Levitskaya J, Sharipo A, Leonchiks A, et al. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci U S A 1997 ; 94 : 12616–12621. [CrossRef] [PubMed] [Google Scholar]
  12. Campanero MR, Flemington EK. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc Natl Acad Sci U S A 1997 ; 94 : 2221–2226. [CrossRef] [PubMed] [Google Scholar]
  13. Johnson DG. Regulation of E2F–1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 1995 ; 11 : 1685–1692. [Google Scholar]
  14. Gnanasundram SV, Pyndiah S, Daskalogianni C, et al. PI3Kδ activates E2F1 synthesis in response to mRNA translation stress. Nat Commun 2017 ; 8 : 2103. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.